Matthias Schroff

Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study

Peter Möller, Yuansheng Sun, Tomislav Dorbic et al. · British Journal of Cancer · 1998 · 100 citations · Full text

Medicine, Immunology, Oncology +17

A Novel Minimal-Size Vector (MIDGE) Improves Transgene Expression in Colon Carcinoma Cells and Avoids Transfection of Undesired DNA

Frank Schakowski, Marcus Gorschlüter, Claas Junghans et al. · Molecular Therapy · 2001 · 100 citations · Full text

Life Sciences, Biotechnology, Molecular Biology +16

Immunization of Cats against Feline Immunodeficiency Virus (FIV) Infection by Using Minimalistic Immunogenic Defined Gene Expression Vector Vaccines Expressing FIV gp140 Alone or with Feline Interleukin-12 (IL-12), IL-16, or a CpG Motif

Christian M. Leutenegger, Felicitas S. Boretti, Caroline N. Mislin et al. · Journal of Virology · 2000 · 85 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Modular Multiantigen T Cell Epitope–Enriched DNA Vaccine Against Human Leishmaniasis

Shantanabha Das, Anja Freier, Thouraya Boussoffara et al. · Science Translational Medicine · 2014 · 71 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours

Martin R. Weihrauch, Heike Richly, Michael S. von Bergwelt‐Baildon et al. · European Journal of Cancer · 2014 · 66 citations

Medicine, Oncology, Pharmacology +15